NSPR InspireMD, Inc.: Operating Margin

The yield from core operations, as reflected in GURU.Markets quotes, reveals the pragmatic approach of the Israeli management regarding expansion into the US. Unique embolism protection allows InspireMD, Inc. (NSPR) to maintain high profitability. Demand for stents remains independent of economic conditions, driven instead by an aging population. The current status is -467.70, which helps assess business efficiency without unnecessary noise.
InspireMD, Inc. - analytical breakdowns and key metrics (NSPR)

Operating margin is calculated as the ratio of operating income to revenue, providing a real-time assessment of cost management efficiency and internal business profitability. This indicator measures the company's ability to generate cash flow before accounting for financial obligations, while the current operating margin confirms the pricing power of InspireMD, Inc. (NSPR) due to the exclusivity of its anti-embolic technologies.